ArticleThe Journal of infectious diseases2019

Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis.

Matthew A Hulverson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.